secwatch.observer — SEC 8-K summary
======================================

Issuer:     Roivant Sciences Ltd. (ROIV)
CIK:        0001635088
Form:       8-K
Filed at:   2022-11-23T23:59:59+00:00
Accession:  0001140361-22-043040
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Andrew Lo resigns from Roivant Sciences board effective Nov 17, 2022
-----------------------------------------------------------------------------

- Dr. Andrew Lo, Class II director, resigned to focus on other ventures; no disagreement with company.
- Resignation effective November 17, 2022.
- Board expressed gratitude for Dr. Lo's years of service.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1635088/000114036122043040/0001140361-22-043040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1635088/000114036122043040/brhc10044578_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-22-043040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer